References
- KhannaAMahalingamKChakrabartiDPeriyasamyGETS-1 expression and gemcitabine chemoresistance in pancreatic cancer cellsCell Mol Biol Lett20111610111321225469
- TemperoMABerlinJDucreuxMPancreatic cancer treatment and research: an international expert panel discussionAnn Oncol2011221500150621199884
- JemalASiegelRXuJWardECancer Statistics, 2010CA Cancer J Clin20106027730020610543
- OikawaTYamadaTMolecular biology of the ETS family of transcription factorsGene2003303113412559563
- FujimotoJAokiIToyokiHClinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancersOncology20046642042815331930
- OzakiIMizutaTZhaoGInduction of multiple matrix metal-loproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor ETS-1Hepatol Res20032728930114662117
- YamaguchiENakayamaTNanashimaAETS-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinomaTohoku J Exp Med2007213415017785952
- ItoHDuxburyMBenoitEProstaglandin E2 enhances pancreatic cancer invasiveness through an ETS-1-dependent induction of matrix metalloproteinase-2Cancer Res2004647439744615492268
- LiYYWuYTsuneyamaKBabaTMukaidaNEssential contribution of ETS-1 to constitutive Pim-3 expression in human pancreatic cancer cellsCancer Sci200910039640419154409
- LefterLPDimaSSunamuraMTranscriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancerCancer Gene Ther20091613714818772901
- GuoQLYouQDWuZQYuanSTZhaoLGeneral gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude miceActa Pharmacol Sin20042576977415169630
- YuJGuoQLYouQDGambogic acid-induced G(2)/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cellsCarcinogenesis20072863263817012222
- KasibhatlaSJessenKAMaliartchoukSA role for transferrin receptor in triggering apoptosis when targeted with gambogic acidProc Natl Acad Sci U S A2005102120951210016103367
- WuZQGuoQLYouQDZhaoLGuHYGambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cellsBiol Pharm Bull2004271769177415516720
- WangCZhangHChenBYinHWangWStudy of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticlesInt J Nanomedicine201161929193521931488
- ZhuXZhangCWuXLPreparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivativesDrug Dev Ind Pharm2008342918214750
- WangJQSuiMHFanWMNanoparticles for tumor targeted therapies and their pharmacokineticsCurr Drug Metab20101112914120359289
- ZhangHJChenBAJiangHWangCLWangHPWangXMA strategy for ZnO nanorod mediated multi-mode cancer treatmentBiomaterials2011321906191421145104
- WuWWChenBAChengJBiocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignanciesInt J Nanomedicine201051079108421170355
- WangJChenBAChengJApoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrinInt J Nanomedicine201161027103421720514
- LinBLShenXDCuiSApplication of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release propertiesBiomed Mater2007213213418458446
- ZhuAYuanLJinWPolysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and releaseActa Biomater200951489149819286431
- ChinSFIyerKSSaundersMEncapsulation and sustained release of curcumin using superparamagnetic silica reservoirsChem Eur J2009155661566519396886
- ChenBALiangYQWuWWSynergistic effect of magnetic nanoparticles of Fe3O4 with gambogic acid on apoptosis of K562 leukemia cellsInt J Nanomedicine2009425125920011242
- ZhangDWZhangHNieJYangJSynthesis and self-assembly behavior of pH-responsive amphiphilic copolymers containing ketal functional groupsPolym Int201059967974
- HuangHChenDLiSGambogic acid enhances proteasome inhibitor-induced anticancer activityCancer Lett201130122122821216092
- BarefordLASwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Deliv Rev20075974875817659804
- YooHSLeeKHOhJEParkTGIn vitro and in vivo anticancer activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release20006841943110974396
- WangLKuangLPanXIsoalvaxanthone inhibits colon cancer cell proliferation, migration and invasion through inactivating Rac1 and AP-1Int J Cancer20101271220122920017136
- TaniguchiHFujiwaraYDokiYGene therapy using eTS-1 transcription factor decoy for peritoneal dissemination of gastric cancerInt J Cancer20071211609161717546598
- PengYLiHWuMNGX6 inhibits AP-1 and ETS-1 expression and down-regulates cyclin D1 in human colorectal cancerActa Biochim Biophys Sin (Shanghai)20094150451419499154
- GuptaRChettyCBhoopathiPDownregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cellsInt J Oncol20113873374421181094
- LuNYangYYouQDGambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1Cancer Lett2007258808917920764